Opposite Effects of the Acute Promyelocytic Leukemia PML-Retinoic Acid Receptor a (RARa) and PLZF-RARa Fusion Proteins on Retinoic Acid Signalling

نویسندگان

  • MARTIN RUTHARDT
  • UGO TESTA
  • FRANCESCO FERRUCCI
  • FRANCESCO GRIGNANI
  • ELENA PUCCETTI
  • FAUSTO GRIGNANI
  • CESARE PESCHLE
چکیده

MARTIN RUTHARDT, UGO TESTA, CLARA NERVI, PIER FRANCESCO FERRUCCI, FRANCESCO GRIGNANI, ELENA PUCCETTI, FAUSTO GRIGNANI, CESARE PESCHLE, AND PIER GIUSEPPE PELICCI* Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Istituto di Medicina Interna e Scienze Oncologiche, Policlinico Monteluce, Perugia University, 06100 Perugia, Department of Haematology and Oncology, Istituto Superlore di Sanità, 00161 Rome, and Dipartmento di Istologia ed Embriologia Medica, University of Rome “La Sapienza,” 00161 Rome, Italy, and Thomas Jefferson University, Philadelphia, Pennsylvania 19107-5541

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

شناسایی الحاق PLZF-RARa در بیماران با ریخت شناسی لوسمی پرومیلوسیتی حاد

Background and Aim: Acute promyelocytic leukemia (APL) is associated with the t(1517) ,fusing promyelocytic leukemia (PML) and retinoic acid receptor-a (RARa) genes. This disease is uniquely sensitive to treatment with all-trans retinoic acid (ATRA) and highly responsive to conventional chemotherapy. The t(1117)(q23q21) abnormality associated with a PLZF-RARa rearrangement is the commonest of t...

متن کامل

SPECIAL FOCUS Reduced Retinoic Acid-Sensitivities of Nuclear Receptor Corepressor Binding to PML- and PLZF-RARa Underlie Molecular Pathogenesis and Treatment of Acute Promyelocytic Leukemia

Typical acute promyelocytic leukemia (APL) is associated with expression of the PML-RARa fusion protein and responsiveness to treatment with all-trans retinoic acid (ATRA). A rare, but recurrent, APL has been described that does not respond to ATRA treatment and is associated with a variant chromosomal translocation and expression of the PLZFRARa fusion protein. Both PMLand PLZF-RARa possess id...

متن کامل

Acute promyelocytic leukemia: relieving repression induces remission.

RETINOIDS AND IN particular retinoic acid are naturally occurring compounds that regulate the growth and differentiation of a variety of different cell types. The observation that retinoic acid induces the terminal differentiation of human acute promyelocytic leukemia (APL) cells both in vitro1 and in vivo2-4 has had a significant impact in clinical hematology and has altered our approach to th...

متن کامل

Cytogenetic and FMS-Like Tyrosine Kinase 3 Mutation Analyses in Acute Promyelocytic Leukemia Patients

Background: The secondary genetic changes other than the promyelocytic leukemia-retinoic acid receptor (PML-RARA) fusion gene may contribute to the acute promyelocytic leukemogenesis. Chromosomal alterations and mutation of FLT3 (FMS-like tyrosine kinase 3) tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia. However, the prognostic significance of FLT3 mutat...

متن کامل

The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation.

Ectopic repression of retinoic acid (RA) receptor target genes by PML/RARA and PLZF/RARA fusion proteins through aberrant recruitment of nuclear corepressor complexes drives cellular transformation and acute promyelocytic leukemia (APL) development. In the case of PML/RARA, this repression can be reversed through treatment with all-trans RA (ATRA), leading to leukemic remission. However, PLZF/R...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 1996